Dole plc(NYSE:DOLE) 
Dole PLC grows, sources, imports, packs, markets, and distributes fresh fruit and vegetables. It grows bananas and pineapples, berries, avocados, and organic products. The company sells and distributes its fruit and vegetable products across retail, wholesale, and foodservice channels in North Ameri...
Website: https://www.doleplc.com/
Founded: 1851
CEO: David H. Murdock
Sector: Consumer Defensive
Industry: Farm Products
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-12-15 | 2021-12-02 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenues | 2,342,175,000 | 1,701,686,500 | 2,278,915,000 | 2,428,427,000 | 2,099,404,000 | 1,576,969,750 | 2,062,414,000 | 2,124,091,000 | 2,121,374,000 | 1,543,253,250 | 2,042,672,000 | 2,141,174,000 | 1,989,167,000 | 1,718,163,750 | 2,267,538,000 | 2,360,135,000 | 2,244,982,000 | 2,260,737,000 | 1,942,185,000 | |
cost of sales | -2,157,182,000 | -2,207,527,000 | -2,123,734,000 | -2,210,127,000 | -1,917,211,000 | -2,009,045,000 | -1,898,375,000 | -1,923,505,000 | -1,926,697,000 | -1,920,077,000 | -1,876,292,000 | -1,944,601,000 | -1,810,128,000 | -2,198,911,000 | -2,134,062,000 | -2,190,228,000 | -2,110,943,000 | -2,074,069,000 | -1,843,415,000 | |
gross profit | 184,993,000 | 158,634,000 | 155,181,000 | 218,300,000 | 182,193,000 | 158,419,000 | 164,039,000 | 200,586,000 | 194,677,000 | 152,178,000 | 166,380,000 | 196,573,000 | 179,039,000 | 157,287,000 | 133,476,000 | 169,907,000 | 134,039,000 | 186,668,000 | 98,770,000 | |
yoy | 1.54% | 0.14% | -5.40% | 8.83% | -6.41% | 4.10% | -1.41% | 2.04% | 8.73% | -3.25% | 24.65% | 15.69% | 33.57% | -28.50% | 72.02% | |||||
qoq | 16.62% | 2.23% | -28.91% | 19.82% | 15.01% | -3.43% | -18.22% | 3.04% | 27.93% | -8.54% | -15.36% | 9.79% | 13.83% | 17.84% | -21.44% | 26.76% | 88.99% | |||
selling, marketing, general and administrative expenses | -123,780,000 | -129,135,000 | -123,621,000 | -124,308,000 | -118,412,000 | -122,675,000 | -115,829,000 | -116,604,000 | -118,950,000 | -119,334,000 | -118,023,000 | -115,667,000 | -120,879,000 | -127,669,000 | -116,326,000 | -123,558,000 | -124,159,000 | |||
gain on disposal of businesses | 1,192,000 | 54,000 | 143,000 | 48,000 | 361,000 | -50,000 | 242,000 | 1,539,000 | ||||||||||||
gain on asset sales | 667,000 | 1,079,000 | 842,000 | 9,323,000 | 3,801,000 | 747,000 | 1,573,000 | -89,000 | 417,000 | 10,666,000 | 28,746,000 | 10,723,000 | 3,973,000 | 2,559,000 | 654,000 | 7,926,000 | 495,000 | 127,000 | 135,000 | |
impairment and asset write-downs of property, plant and equipment and lease assets | -1,112,000 | -2,942,000 | -8,394,000 | |||||||||||||||||
operating income | 61,960,000 | 27,690,000 | 24,151,000 | 103,219,000 | 67,905,000 | 34,809,000 | 47,734,000 | 85,888,000 | 112,133,000 | 41,293,000 | 77,103,000 | 91,629,000 | 62,133,000 | 31,730,000 | 17,804,000 | 54,275,000 | 10,617,000 | 33,859,000 | -27,161,000 | |
yoy | -8.75% | -20.45% | -49.41% | 20.18% | -39.44% | -15.70% | -38.09% | -6.27% | 80.47% | 30.14% | 333.07% | 68.82% | 485.22% | -47.42% | -299.83% | |||||
qoq | 123.76% | 14.65% | -76.60% | 52.01% | 95.08% | -27.08% | -44.42% | -23.41% | 171.55% | -46.44% | -15.85% | 47.47% | 95.82% | 78.22% | -67.20% | 411.21% | -224.66% | |||
other income | 4,538,000 | 4,876,000 | 12,614,000 | -18,716,000 | -348,000 | 11,137,000 | -4,541,000 | 6,377,000 | 7,622,000 | -2,922,000 | 4,817,000 | 1,129,000 | 1,775,000 | -9,112,000 | 9,312,000 | 8,605,000 | 2,517,000 | 700,000 | 7,167,000 | |
interest income | 4,205,000 | 3,900,000 | 3,478,000 | 2,955,000 | 3,040,000 | 2,410,000 | 2,632,000 | 2,624,000 | 3,079,000 | 2,823,000 | 2,311,000 | 2,640,000 | 2,309,000 | 2,046,000 | 1,505,000 | 1,453,000 | 1,638,000 | 836,000 | 990,000 | |
interest expense | -12,586,000 | -15,202,000 | -16,641,000 | -17,516,000 | -17,182,000 | -18,055,000 | -17,473,000 | -18,788,000 | -17,948,000 | -18,754,000 | -20,899,000 | -19,748,000 | -21,712,000 | -19,761,000 | -17,095,000 | -12,985,000 | -11,644,000 | -4,846,000 | -9,341,000 | |
income from continuing operations before income taxes and equity earnings | 58,117,000 | 21,264,000 | 23,602,000 | 69,942,000 | 53,415,000 | 30,301,000 | 28,352,000 | 76,101,000 | 104,886,000 | 22,440,000 | 63,332,000 | 75,650,000 | 44,505,000 | 30,549,000 | -28,345,000 | |||||
income tax expense | -21,982,000 | -21,821,000 | -6,100,000 | -25,504,000 | -17,578,000 | -18,846,250 | -15,524,000 | -25,460,000 | -34,401,000 | -16,593,000 | -10,994,000 | -6,003,000 | -420,000 | -8,239,000 | ||||||
equity method earnings | 1,600,000 | 7,362,000 | 6,559,000 | 8,501,000 | 8,292,000 | -403,000 | 2,303,000 | 5,406,000 | 1,002,000 | 3,683,000 | 5,342,000 | 4,688,000 | 1,478,000 | 2,698,000 | 300,000 | |||||
income from continuing operations | 37,735,000 | 6,805,000 | 24,061,000 | 52,939,000 | 44,129,000 | 29,634,000 | 15,131,000 | 56,047,000 | 71,487,000 | 23,136,000 | 55,657,000 | 63,745,000 | 34,989,000 | |||||||
income from discontinued operations, net of income taxes | -11,289,000 | -10,236,000 | -34,950,000 | 30,000 | 8,087,750 | 6,384,000 | 32,018,000 | |||||||||||||
net income | 37,735,000 | 6,002,000 | 13,825,000 | 17,989,000 | 44,159,000 | -31,597,000 | 21,515,000 | 88,065,000 | 65,436,000 | 28,934,000 | 53,985,000 | 52,307,000 | 20,483,000 | 13,305,000 | 46,604,000 | 48,496,000 | 3,285,000 | 62,947,000 | -21,563,000 | |
yoy | -14.55% | -119.00% | -35.74% | -79.57% | -32.52% | -209.20% | -60.15% | 68.36% | 219.46% | 117.47% | 15.84% | 7.86% | 523.53% | -25.96% | -324.90% | |||||
qoq | 528.71% | -56.59% | -23.15% | -59.26% | -239.76% | -246.86% | -75.57% | 34.58% | 126.16% | -46.40% | 3.21% | 155.37% | 53.95% | -71.45% | -3.90% | 1376.29% | -391.92% | |||
income attributable to noncontrolling interests | -6,438,000 | |||||||||||||||||||
net income attributable to dole plc | 31,297,000 | -2,664,000 | 5,105,000 | 9,966,000 | 38,912,000 | -39,149,000 | 14,402,000 | 80,117,000 | 70,143,000 | 22,337,000 | 45,292,000 | 42,275,000 | 14,159,000 | 6,781,000 | 39,837,000 | 41,272,000 | -1,394,000 | 50,548,000 | -28,516,000 | |
income per share - basic: | ||||||||||||||||||||
continuing operations | 0.33 | -0.02 | 0.16 | 0.47 | 0.41 | 0.24 | 0.08 | 0.51 | 0.8 | 0.18 | 0.5 | 0.57 | 0.3 | |||||||
discontinued operations | -0.01 | -0.11 | -0.37 | -0.65 | 0.07 | 0.34 | -0.06 | 0.06 | -0.02 | -0.12 | -0.15 | |||||||||
net income per share | 0.33 | -0.03 | 0.05 | 0.1 | 0.41 | -0.41 | 0.15 | 0.85 | 0.74 | 0.24 | 0.48 | 0.45 | 0.15 | 0.07 | 0.42 | 0.44 | -0.01 | 0.13 | -0.35 | |
income per share - diluted: | ||||||||||||||||||||
weighted-average shares: | ||||||||||||||||||||
basic | 95,168 | 95,145 | 95,163 | 95,145 | 95,109 | 94,967 | 94,990 | 94,930 | 94,929 | 94,917 | 94,929 | 94,909 | 94,899 | |||||||
diluted | 95,758 | 95,902 | 95,979 | 95,850 | 95,677 | 95,471 | 95,614 | 95,340 | 95,229 | 95,118 | 95,148 | 95,112 | 95,024 | |||||||
impairment of goodwill | -36,684,000 | |||||||||||||||||||
net income attributable to noncontrolling interests | -5,497,500 | -8,720,000 | -8,023,000 | -2,588,500 | -7,113,000 | -7,948,000 | ||||||||||||||
impairment and asset write-downs of property, plant and equipment | -144,000 | -38,000 | -2,154,000 | -2,049,000 | ||||||||||||||||
net loss attributable to noncontrolling interests | -5,247,000 | 4,707,000 | ||||||||||||||||||
gain on disposal of business | 18,986,250 | 1,995,000 | 73,950,000 | |||||||||||||||||
impairment of property, plant and equipment | -1,277,000 | |||||||||||||||||||
loss from discontinued operations, net of income taxes | -6,051,000 | 5,798,000 | -1,672,000 | -11,438,000 | -14,506,000 | |||||||||||||||
income tax benefit | -2,987,000 | -13,017,000 | 5,704,000 | 34,778,000 | 3,401,000 | |||||||||||||||
less: net income attributable to noncontrolling interests | -6,597,000 | -8,693,000 | -10,032,000 | -6,324,000 | -6,524,000 | -6,767,000 | -7,224,000 | -4,679,000 | -12,399,000 | -6,953,000 | ||||||||||
merger, transaction and other related costs | -15,095,000 | -13,719,000 | ||||||||||||||||||
income before income taxes and equity earnings | 4,903,000 | 11,526,000 | 51,348,000 | 3,128,000 | ||||||||||||||||
weighted-average shares outstanding – basic | 94,891 | |||||||||||||||||||
weighted-average shares outstanding – diluted | 94,908 | |||||||||||||||||||
equity in net earnings of investments accounted for under the equity method | 3,151,000 | 577,000 | 40,637,000 | 3,381,000 | ||||||||||||||||
weighted-average shares outstanding - basic | 94,878 | 94,878 | 72,190 | 388,922 | ||||||||||||||||
weighted-average shares outstanding - diluted | 94,913 | 94,878 | 72,190 | 390,580 | ||||||||||||||||
selling, general and administrative expenses | -139,380,000 | |||||||||||||||||||
smg&a expenses | -110,213,000 | |||||||||||||||||||
loss on disposal of businesses | -2,134,000 | |||||||||||||||||||
weighted-average shares outstanding—basic | 82,166 | |||||||||||||||||||
weighted-average shares outstanding—diluted | 82,166 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-12-15 | 2021-12-02 | 2021-09-30 | 2021-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||
cash and cash equivalents | 273,168,000 | 267,854,000 | 314,673,000 | 316,911,000 | 254,878,000 | 330,017,000 | 260,588,000 | 219,649,000 | 239,397,000 | 275,580,000 | 217,523,000 | 231,075,000 | 266,200,000 | 228,840,000 | 221,476,000 | 238,790,000 | 215,948,000 | 250,561,000 | 156,786,000 | 234,214,000 | 234,214,000 | 156,786,000 |
short-term investments | 6,721,000 | 6,418,000 | 6,299,000 | 6,216,000 | 6,132,000 | 6,019,000 | 5,794,000 | 6,182,000 | 6,099,000 | 5,899,000 | 5,735,000 | 5,676,000 | 5,584,000 | 5,367,000 | 5,090,000 | 5,656,000 | 5,584,000 | 6,115,000 | 5,703,000 | |||
trade receivables, net of allowance | 592,602,000 | 539,840,000 | 584,581,000 | 657,055,000 | 619,534,000 | 473,511,000 | 561,737,000 | 549,352,000 | 621,282,000 | 538,177,000 | 575,205,000 | 627,778,000 | 634,785,000 | 605,154,000 | 567,931,000 | 616,318,000 | 785,626,000 | 719,114,000 | 447,973,000 | 776,913,000 | 447,973,000 | |
grower advance receivables, net of allowances of 36,715 and 37,915, respectively | 122,957,000 | |||||||||||||||||||||
other receivables, net of allowances of 17,131 and 17,027, respectively | 130,483,000 | |||||||||||||||||||||
inventories, net of allowances of 3,506 and 3,659, respectively | 490,825,000 | |||||||||||||||||||||
prepaid expenses | 77,960,000 | 70,007,000 | 68,330,000 | 69,717,000 | 72,320,000 | 66,136,000 | 63,554,000 | 64,597,000 | 59,773,000 | 61,724,000 | 59,709,000 | 53,656,000 | 47,342,000 | 55,045,000 | 56,134,000 | 55,125,000 | 58,214,000 | 45,339,000 | 21,190,000 | 53,403,000 | 21,190,000 | |
other current assets | 16,598,000 | 17,891,000 | 20,708,000 | 16,662,000 | 19,295,000 | 15,111,000 | 15,883,000 | 20,239,000 | 17,149,000 | 17,401,000 | 33,303,000 | 33,495,000 | 23,688,000 | 15,034,000 | 27,694,000 | 18,200,000 | 16,309,000 | 11,011,000 | 2,218,000 | 12,703,000 | 2,218,000 | |
assets held for sale | 78,506,000 | 75,689,000 | ||||||||||||||||||||
total current assets | 1,789,820,000 | 1,751,740,000 | 1,765,796,000 | 2,080,669,000 | 1,962,733,000 | 1,884,713,000 | 1,959,873,000 | 1,934,595,000 | 1,986,874,000 | 1,920,689,000 | 1,922,227,000 | 1,959,601,000 | 2,015,655,000 | 1,605,478,000 | 1,635,504,000 | 1,608,657,000 | 1,782,186,000 | 1,641,335,000 | 820,522,000 | 1,721,483,000 | 820,522,000 | |
long-term investments | 13,330,000 | 13,827,000 | 14,198,000 | 14,294,000 | 14,403,000 | 14,630,000 | 15,661,000 | 15,302,000 | 15,696,000 | 15,970,000 | 15,468,000 | 16,572,000 | 16,619,000 | 16,498,000 | 17,347,000 | 18,832,000 | 21,405,000 | 23,433,000 | 24,491,000 | |||
investments in unconsolidated affiliates | 140,788,000 | 142,082,000 | 142,712,000 | 138,128,000 | 128,714,000 | 129,322,000 | 136,122,000 | 131,470,000 | 130,992,000 | 131,704,000 | 127,429,000 | 125,828,000 | 125,377,000 | 124,239,000 | 115,952,000 | 122,652,000 | 126,846,000 | 128,407,000 | 492,045,000 | 126,774,000 | 492,045,000 | |
actively marketed property | 53,231,000 | 53,231,000 | 55,887,000 | 45,391,000 | 45,391,000 | 45,778,000 | 13,781,000 | 13,781,000 | 13,781,000 | 13,781,000 | 13,781,000 | 29,393,000 | 29,393,000 | 31,007,000 | 36,842,000 | 37,001,000 | 37,001,000 | 50,364,000 | 50,638,000 | |||
property, plant and equipment, net of accumulated depreciation | 1,057,452,000 | 1,081,656,000 | 1,118,915,000 | 1,099,285,000 | 1,079,824,000 | 1,082,056,000 | 1,125,511,000 | 1,077,675,000 | 1,086,843,000 | 1,102,234,000 | 1,085,778,000 | 1,100,599,000 | 1,105,179,000 | 1,343,307,000 | 1,323,421,000 | 1,349,732,000 | 1,394,556,000 | 1,430,850,000 | 213,140,000 | 1,446,773,000 | 213,140,000 | |
operating lease right-of-use assets | 404,388,000 | 371,366,000 | 352,708,000 | 357,685,000 | 337,351,000 | 337,468,000 | 319,730,000 | 315,801,000 | 326,817,000 | 340,458,000 | 312,608,000 | 322,461,000 | 317,218,000 | 392,797,000 | 358,699,000 | 372,416,000 | 363,045,000 | 368,632,000 | 127,278,000 | 363,990,000 | 127,278,000 | |
goodwill | 431,329,000 | 434,345,000 | 449,180,000 | 448,798,000 | 438,334,000 | 429,590,000 | 441,792,000 | 434,797,000 | 435,962,000 | 513,312,000 | 500,892,000 | 502,309,000 | 503,259,000 | 497,453,000 | 487,524,000 | 494,146,000 | 509,174,000 | 511,333,000 | 234,813,000 | 511,133,000 | 234,813,000 | |
dole® brand | 306,280,000 | 306,280,000 | ||||||||||||||||||||
other intangible assets, net of accumulated amortization of 133,304 and 133,022, respectively | 17,371,000 | |||||||||||||||||||||
other assets | 142,018,000 | 133,931,000 | 140,962,000 | 116,538,000 | 98,336,000 | 108,804,000 | 100,913,000 | 110,707,000 | 104,667,000 | 109,048,000 | 139,598,000 | 139,580,000 | 132,189,000 | 159,681,000 | 147,017,000 | 128,777,000 | 125,855,000 | 98,917,000 | 43,596,000 | 75,592,000 | 43,596,000 | |
deferred tax assets | 93,059,000 | 88,669,000 | 85,695,000 | 83,836,000 | 81,880,000 | 82,484,000 | 69,475,000 | 69,630,000 | 69,004,000 | 66,485,000 | 70,263,000 | 69,640,000 | 70,080,000 | 64,112,000 | ||||||||
total assets | 4,449,066,000 | 4,396,124,000 | 4,452,835,000 | 4,713,282,000 | 4,516,936,000 | 4,446,363,000 | 4,516,354,000 | 4,438,616,000 | 4,507,559,000 | 4,561,193,000 | 4,537,675,000 | 4,618,489,000 | 4,669,842,000 | 4,591,842,000 | 4,527,868,000 | 4,544,088,000 | 4,773,260,000 | 4,667,968,000 | 2,000,994,000 | 4,729,944,000 | 4,729,944,000 | 2,000,994,000 |
liabilities and equity | ||||||||||||||||||||||
accounts payable | 702,770,000 | 712,483,000 | 706,669,000 | 727,335,000 | 670,897,000 | 648,586,000 | 641,543,000 | 592,724,000 | 599,445,000 | 670,904,000 | 619,914,000 | 650,967,000 | 624,045,000 | 729,615,000 | 657,116,000 | 738,588,000 | 695,513,000 | 696,766,000 | 489,628,000 | 696,433,000 | 489,628,000 | |
income taxes payable | 27,191,000 | 21,805,000 | 36,516,000 | 47,052,000 | 54,140,000 | 42,753,000 | 66,495,000 | 68,131,000 | 63,396,000 | 22,917,000 | 33,773,000 | 30,041,000 | 20,624,000 | 11,558,000 | 17,190,000 | 13,764,000 | 5,427,000 | 10,316,000 | 6,392,000 | 21,484,000 | 6,392,000 | |
accrued liabilities | 477,705,000 | 517,989,000 | 489,299,000 | 429,844,000 | 430,386,000 | 437,017,000 | 388,157,000 | 360,269,000 | 417,767,000 | 357,427,000 | 380,196,000 | 329,608,000 | 387,378,000 | 465,626,000 | 474,865,000 | 390,257,000 | 429,297,000 | 464,931,000 | 108,139 | 431,344,000 | 108,139 | |
bank overdrafts | 12,696,000 | 9,611,000 | 14,706,000 | 25,404,000 | 9,433,000 | 11,443,000 | 16,451,000 | 38,613,000 | 12,054,000 | 11,488,000 | 13,772,000 | 20,285,000 | 11,898,000 | 8,623,000 | 20,284,000 | 19,977,000 | 15,883,000 | 9,395,000 | 35,194,000 | 27,579,000 | 35,194,000 | |
current portion of long-term debt | 40,633,000 | 57,668,000 | 57,445,000 | 73,639,000 | 44,744,000 | 80,097,000 | 87,023,000 | 55,201,000 | 215,281,000 | 222,940,000 | 255,953,000 | 268,203,000 | 255,052,000 | 97,435,000 | ||||||||
current maturities of operating leases | 78,501,000 | 71,379,000 | 68,192,000 | 68,144,000 | 64,342,000 | 62,896,000 | 62,597,000 | 61,651,000 | 62,910,000 | 63,653,000 | 59,702,000 | 61,458,000 | 61,216,000 | 81,968,000 | 86,563,000 | 75,585,000 | 73,292,000 | 73,046,000 | 21,729,000 | 68,449,000 | 21,729,000 | |
payroll and other tax | 37,256,000 | 36,320,000 | 26,348,000 | 32,499,000 | 35,247,000 | 28,056,000 | 22,094,000 | 25,704,000 | 26,032,000 | 27,791,000 | 23,811,000 | 30,329,000 | 26,407,000 | 28,913,000 | ||||||||
contingent consideration | 3,734,000 | 3,252,000 | 4,652,000 | 4,745,000 | 3,280,000 | 3,399,000 | 1,037,000 | 1,099,000 | 1,152,000 | 1,788,000 | 663,000 | 644,000 | 603,000 | 1,791,000 | 1,700,000 | 3,065,000 | 3,037,000 | 2,958,000 | 7,019,000 | 6,266,000 | 7,019,000 | |
pension and other postretirement benefits | 18,552,000 | 18,114,000 | 18,116,000 | 18,309,000 | 15,466,000 | 15,725,000 | 16,038,000 | 15,878,000 | 16,456,000 | |||||||||||||
liabilities held for sale | 16,331,000 | 14,047,000 | ||||||||||||||||||||
dividends payable and other current liabilities | 16,064,000 | 31,228,000 | 38,428,000 | 22,934,000 | 21,903,000 | 14,696,000 | 14,738,000 | 39,723,000 | 24,580,000 | 29,892,000 | 21,994,000 | 32,198,000 | 18,357,000 | 17,698,000 | 19,313,000 | 10,129,000 | 18,232,000 | 9,078,000 | ||||
total current liabilities | 1,431,433,000 | 1,494,481,000 | 1,460,369,000 | 1,645,449,000 | 1,559,088,000 | 1,592,103,000 | 1,585,480,000 | 1,534,466,000 | 1,744,408,000 | 1,716,712,000 | 1,720,244,000 | 1,742,318,000 | 1,734,092,000 | 1,460,514,000 | 1,400,184,000 | 1,380,677,000 | 1,378,455,000 | 1,371,151,000 | 751,631,000 | 1,435,749,000 | 751,631,000 | |
long-term debt | 870,176,000 | 799,814,000 | 899,299,000 | 998,876,000 | 933,983,000 | 866,075,000 | 878,785,000 | 882,287,000 | 774,361,000 | 845,013,000 | 859,677,000 | 930,421,000 | 1,013,984,000 | 1,127,321,000 | 1,208,152,000 | 1,182,012,000 | 1,387,941,000 | 1,297,808,000 | 335,990,000 | 1,262,334,000 | 335,990,000 | |
operating leases, less current maturities | 331,951,000 | 306,566,000 | 290,290,000 | 293,669,000 | 278,654,000 | 280,836,000 | 262,681,000 | 258,229,000 | 269,735,000 | 287,991,000 | 262,160,000 | 269,274,000 | 266,226,000 | 320,272,000 | 278,429,000 | 302,467,000 | 298,194,000 | 305,714,000 | 110,823,000 | 306,634,000 | 110,823,000 | |
deferred tax liabilities | 94,770,000 | 90,100,000 | 76,720,000 | 68,568,000 | 74,469,000 | 79,598,000 | 79,956,000 | 83,892,000 | 83,704,000 | 92,653,000 | 112,333,000 | 119,148,000 | 118,606,000 | 143,376,000 | ||||||||
contingent consideration, less current portion | 889,000 | 500,000 | 1,202,000 | 1,195,000 | 3,064,000 | 4,007,000 | 7,725,000 | 7,252,000 | 7,356,000 | 7,327,000 | 7,542,000 | 6,254,000 | 6,482,000 | 5,022,000 | 4,729,000 | 5,490,000 | 4,106,000 | 4,302,000 | 3,786,000 | 3,835,000 | 3,786,000 | |
pension and other postretirement benefits, less current portion | 133,010,000 | 129,617,000 | 130,944,000 | 130,678,000 | 113,718,000 | 116,640,000 | 113,418,000 | 117,946,000 | 119,663,000 | |||||||||||||
other long-term liabilities | 67,956,000 | 66,990,000 | 75,479,000 | 50,821,000 | 52,538,000 | 52,746,000 | 52,962,000 | 48,461,000 | 51,990,000 | 52,295,000 | 43,906,000 | 43,871,000 | 44,141,000 | 61,248,000 | 62,507,000 | 96,418,000 | 105,944,000 | 105,310,000 | 16,720,000 | 133,417,000 | 16,720,000 | |
total liabilities | 2,930,185,000 | 2,894,351,000 | 2,932,976,000 | 3,189,522,000 | 3,038,684,000 | 3,011,445,000 | 2,981,307,000 | 2,931,227,000 | 3,061,636,000 | 3,140,344,000 | 3,140,729,000 | 3,247,870,000 | 3,332,750,000 | 3,272,857,000 | 3,270,666,000 | 3,291,754,000 | 3,512,007,000 | 3,422,562,000 | 1,277,717,000 | 3,449,783,000 | 1,277,717,000 | |
contingencies | ||||||||||||||||||||||
redeemable noncontrolling interests | 31,917,000 | 29,716,000 | 32,568,000 | 35,398,000 | 33,114,000 | 35,554,000 | 34,790,000 | 33,817,000 | 33,766,000 | 34,185,000 | 34,182,000 | 34,391,000 | 32,964,000 | 32,311,000 | 31,770,000 | 33,462,000 | 33,949,000 | 32,776,000 | 32,199,000 | 31,627,000 | 32,199,000 | |
stockholders’ equity: | ||||||||||||||||||||||
common stock — 0.01 par value... | 955,000 | 952,000 | 952,000 | 952,000 | 951,000 | 950,000 | 950,000 | 950,000 | 949,000 | 949,000 | 949,000 | 949,000 | 949,000 | 949,000 | 949,000 | |||||||
additional paid-in capital | 798,607,000 | 804,247,000 | 800,225,000 | 798,457,000 | 796,920,000 | 801,099,000 | 801,919,000 | 801,774,000 | 799,515,000 | 796,800,000 | 796,290,000 | 795,059,000 | 794,864,000 | 795,063,000 | 793,521,000 | 793,528,000 | 792,061,000 | 792,223,000 | 198,668 | 794,085,000 | 198,668 | |
retained earnings | 699,467,000 | 676,371,000 | 687,242,000 | 690,355,000 | 688,607,000 | 657,430,000 | 704,047,000 | 697,504,000 | 624,983,000 | 562,562,000 | 547,912,000 | 510,306,000 | 475,718,000 | 469,249,000 | 470,125,000 | 437,983,000 | 404,334,000 | 413,335,000 | 478,709,000 | 450,193,000 | 478,709,000 | |
accumulated other comprehensive loss | -122,992,000 | -117,467,000 | -108,529,000 | -113,372,000 | -148,664,000 | -166,180,000 | -117,000,000 | -129,373,000 | -122,124,000 | -110,791,000 | -112,967,000 | -97,613,000 | -100,911,000 | -104,133,000 | -154,137,000 | -130,699,000 | -100,962,000 | -125,919,000 | -112,215,000 | -128,485,000 | -112,215,000 | |
total equity attributable to dole plc | 1,376,037,000 | 1,364,103,000 | 1,379,890,000 | 1,376,392,000 | 1,337,814,000 | 1,293,299,000 | 1,389,916,000 | 1,370,855,000 | 1,303,323,000 | 1,249,520,000 | 1,232,184,000 | 1,208,701,000 | 1,170,620,000 | 1,161,128,000 | 1,110,458,000 | 1,101,762,000 | 1,096,383,000 | 1,080,589,000 | 570,043,000 | 1,116,742,000 | 570,043,000 | |
equity attributable to noncontrolling interests | 110,927,000 | 107,954,000 | 107,401,000 | 111,970,000 | 107,324,000 | 106,065,000 | 110,341,000 | 102,717,000 | 108,834,000 | 137,144,000 | 130,580,000 | 127,527,000 | 133,508,000 | 125,546,000 | 114,974,000 | 117,110,000 | 130,921,000 | 132,041,000 | 121,035,000 | 131,792,000 | 121,035,000 | |
total equity | 1,486,964,000 | 1,472,057,000 | 1,487,291,000 | 1,488,362,000 | 1,445,138,000 | 1,399,364,000 | 1,500,257,000 | 1,473,572,000 | 1,412,157,000 | 1,386,664,000 | 1,362,764,000 | 1,336,228,000 | 1,304,128,000 | 1,286,674,000 | 1,225,432,000 | 1,218,872,000 | 1,227,304,000 | 1,212,630,000 | 691,078,000 | 1,248,534,000 | 1,248,534,000 | 691,078,000 |
total liabilities, redeemable noncontrolling interests and equity | 4,449,066,000 | 4,396,124,000 | 4,452,835,000 | 4,713,282,000 | 4,516,936,000 | 4,446,363,000 | 4,516,354,000 | 4,438,616,000 | 4,507,559,000 | 4,561,193,000 | 4,537,675,000 | 4,618,489,000 | 4,669,842,000 | 4,591,842,000 | 4,527,868,000 | 4,544,088,000 | 4,773,260,000 | 4,667,968,000 | 2,000,994,000 | 4,729,944,000 | 4,729,944,000 | 2,000,994,000 |
grower advance receivables, net of allowances of 37,915 and 29,304, respectively | 143,426,000 | |||||||||||||||||||||
other receivables, net of allowances of 17,027 and 15,248, respectively | 121,355,000 | |||||||||||||||||||||
inventories, net of allowances of 3,659 and 4,178, respectively | 509,260,000 | |||||||||||||||||||||
fresh vegetables current assets held for sale | 351,177,000 | 318,837,000 | 332,042,000 | 423,743,000 | 484,416,000 | 405,733,000 | 414,457,000 | 414,222,000 | 390,697,000 | 384,609,000 | ||||||||||||
other intangible assets, net of accumulated amortization of 133,022 and 118,956, respectively | 18,997,000 | |||||||||||||||||||||
pension and postretirement benefits | 18,699,000 | 18,491,000 | 16,570,000 | 17,059,000 | 17,287,000 | 16,873,000 | 17,330,000 | 17,857,000 | 17,664,000 | 5,605,000 | 20,608,000 | 5,605,000 | ||||||||||
fresh vegetables current liabilities held for sale | 195,737,000 | 206,407,000 | 244,669,000 | 269,879,000 | 275,626,000 | 305,753,000 | 291,342,000 | 294,588,000 | 302,129,000 | 311,453,000 | ||||||||||||
income taxes payable, less current portion | 6,210,000 | 6,210,000 | 16,664,000 | 16,664,000 | 16,921,000 | 16,921,000 | 30,458,000 | 30,458,000 | ||||||||||||||
pension and postretirement benefits, less current portion | 135,900,000 | 129,870,000 | 121,689,000 | 118,761,000 | 124,646,000 | 135,790,000 | 142,110,000 | 147,621,000 | 152,149,000 | 23,790,000 | 158,167,000 | 23,790,000 | ||||||||||
grower advance receivables, net of allowances for credit losses of 34,496 and 29,304, respectively | 166,634,000 | |||||||||||||||||||||
other receivables, net of allowances for credit losses of 14,782 and 15,248, respectively | 154,055,000 | |||||||||||||||||||||
inventories, net of allowances of 4,085 and 4,178, respectively | 448,863,000 | |||||||||||||||||||||
other assets held for sale | 1,653,000 | 2,491,000 | 851,000 | 1,654,000 | 1,825,000 | 1,827,000 | 10,318,000 | 10,488,000 | 10,784,000 | |||||||||||||
dole brand | 306,280,000 | 306,280,000 | 306,280,000 | 306,280,000 | 306,280,000 | 306,280,000 | 306,280,000 | 306,280,000 | 306,280,000 | 306,280,000 | 306,280,000 | 306,280,000 | 306,280,000 | 306,280,000 | 306,280,000 | 306,280,000 | 306,280,000 | |||||
other intangible assets, net of accumulated amortization of 132,626 and 118,956, respectively | 20,502,000 | |||||||||||||||||||||
grower advance receivables, net of allowances for credit losses of 34,004 and 29,304, respectively | 107,943,000 | |||||||||||||||||||||
other receivables, net of allowances for credit losses of 14,804 and 15,248, respectively | 136,724,000 | |||||||||||||||||||||
inventories, net of allowances of 4,325 and 4,178, respectively | 415,773,000 | |||||||||||||||||||||
other intangible assets, net of accumulated amortization of 131,007 and 118,956, respectively | 22,378,000 | |||||||||||||||||||||
grower advance receivables, net of allowances for credit losses of 32,850 and 29,304, respectively | 109,786,000 | |||||||||||||||||||||
other receivables, net of allowances for credit losses of 14,959 and 15,248, respectively | 128,107,000 | |||||||||||||||||||||
inventories, net of allowances of 4,269 and 4,178, respectively | 432,993,000 | |||||||||||||||||||||
other intangible assets, net of accumulated amortization of 123,532 and 118,956, respectively | 23,690,000 | |||||||||||||||||||||
grower advance receivables, net of allowances of 29,304 and 19,839, respectively | 104,956,000 | |||||||||||||||||||||
other receivables, net of allowances of 15,248 and 13,227, respectively | 125,412,000 | |||||||||||||||||||||
inventories, net of allowances of 4,178 and 4,792, respectively | 430,090,000 | |||||||||||||||||||||
other assets held-for-sale | 1,419,000 | 1,832,000 | ||||||||||||||||||||
other intangible assets, net of accumulated amortization of 118,956 and 134,420, respectively | 25,238,000 | |||||||||||||||||||||
grower advance receivables, net of allowances for credit losses of 21,025 and 19,839, respectively | 131,708,000 | |||||||||||||||||||||
other receivables, net of allowances for credit losses of 12,944 and 13,227, respectively | 117,223,000 | |||||||||||||||||||||
inventories, net of allowances of 4,786 and 4,792, respectively | 377,989,000 | |||||||||||||||||||||
other intangible assets, net of accumulated amortization of 124,349 and 134,420, respectively | 27,216,000 | |||||||||||||||||||||
grower advance receivables, net of allowances for credit losses of 19,673 and 19,839, respectively | 99,423,000 | |||||||||||||||||||||
other receivables, net of allowances for credit losses of 13,309 and 13,227, respectively | 120,603,000 | |||||||||||||||||||||
inventories, net of allowances of 5,056 and 4,792, respectively | 368,309,000 | |||||||||||||||||||||
other intangible assets, net of accumulated amortization of 118,505 and 134,420, respectively | 28,578,000 | |||||||||||||||||||||
grower advance receivables, net of allowances for credit losses of 17,627 and 19,839, respectively | 105,146,000 | |||||||||||||||||||||
other receivables, net of allowances for credit losses of 13,410 and 13,227, respectively | 120,986,000 | |||||||||||||||||||||
inventories, net of allowances of 4,522 and 4,792, respectively | 409,482,000 | |||||||||||||||||||||
other intangible assets, net of accumulated amortization of 117,551 and 134,420, respectively | 30,643,000 | |||||||||||||||||||||
grower advance receivables, net of allowances of 19,839 and 15,817, respectively | 109,958,000 | |||||||||||||||||||||
other receivables, net of allowances of 13,227 and 14,538, respectively | 117,069,000 | |||||||||||||||||||||
inventories, net of allowances of 4,792 and 4,186, respectively | 378,592,000 | |||||||||||||||||||||
other intangible assets, net of accumulated amortization of 134,420 and 120,315, respectively | 41,232,000 | |||||||||||||||||||||
fresh vegetables non-current assets held for sale | ||||||||||||||||||||||
fresh vegetables non-current liabilities held for sale | ||||||||||||||||||||||
grower advance receivables, net of allowances for credit losses of 20,946 and 15,817, respectively | 124,981,000 | |||||||||||||||||||||
other receivables, net of allowances for credit losses of 13,733 and 14,538, respectively | 114,513,000 | |||||||||||||||||||||
inventories, net of allowances of 3,889 and 4,186, respectively | 366,718,000 | |||||||||||||||||||||
other intangible assets, net of accumulated amortization of 127,462 and 120,315, respectively | 43,351,000 | |||||||||||||||||||||
commitments and contingent liabilities | ||||||||||||||||||||||
grower advance receivables, net of allowances for credit losses of 17,018 and 15,817, respectively | 112,517,000 | |||||||||||||||||||||
other receivables, net of allowances for credit losses of 13,869 and 14,538, respectively | 142,167,000 | |||||||||||||||||||||
inventories, net of allowances of 3,322 and 4,186, respectively | 352,052,000 | |||||||||||||||||||||
other intangible assets, net of accumulated amortization of 127,373 and 120,315, respectively | 46,226,000 | |||||||||||||||||||||
grower advance receivables, net of allowances for credit losses of 16,462 and 15,817, respectively | 112,818,000 | |||||||||||||||||||||
other receivables, net of allowances for credit losses of 14,377 and 14,538, respectively | 124,292,000 | |||||||||||||||||||||
inventories, net of allowances of 9,760 and 4,186, respectively | 405,553,000 | |||||||||||||||||||||
other intangible assets, net of accumulated amortization of 124,470 and 120,315, respectively | 48,593,000 | |||||||||||||||||||||
grower advance receivables, net of allowances of 15,817 and 9,606, respectively | 120,940,000 | |||||||||||||||||||||
other receivables, net of allowances of 14,810 and 14,066, respectively | 137,575,000 | |||||||||||||||||||||
inventories, net of allowances of 4,410 and 7,447, respectively | 436,878,000 | |||||||||||||||||||||
assets held-for-sale | 645,000 | 80,000 | 80,000 | 2,974,000 | 200,000 | 435,000 | ||||||||||||||||
other intangible assets, net of accumulated amortization of 120,315 and 117,499 respectively | 50,990,000 | |||||||||||||||||||||
grower advance receivables, net of allowances for credit losses of 10,650 and 9,606, respectively | 149,086,000 | |||||||||||||||||||||
other receivables, net of allowances for credit losses of 14,235 and 14,066, respectively | 156,087,000 | |||||||||||||||||||||
inventories, net of allowances of 1,949 and 7,447, respectively | 451,926,000 | |||||||||||||||||||||
other intangible assets, net of accumulated amortization of 112,087 and 117,499, respectively | 52,103,000 | |||||||||||||||||||||
deferred income tax assets | 47,179,000 | 49,835,000 | 47,238,000 | 46,371,000 | 7,073,000 | 39,569,000 | 7,073,000 | |||||||||||||||
notes payable and current portion of long-term debt | 78,984,000 | 81,219,000 | 83,792,000 | 51,785,000 | 20,303,000 | 52,241,000 | 20,303,000 | |||||||||||||||
other tax | 27,296,000 | 30,763,000 | 36,125,000 | 35,212,000 | 18,238 | 52,158,000 | 18,238 | |||||||||||||||
deferred income tax liabilities | 150,374,000 | 152,251,000 | 149,307,000 | 145,689,000 | 34,977,000 | 149,647,000 | 34,977,000 | |||||||||||||||
income tax payable, less current portion | 30,501,000 | 30,329,000 | 40,439,000 | 40,439,000 | ||||||||||||||||||
grower advance receivables, net of allowances of 8,656 and 9,606, respectively | 88,213,000 | |||||||||||||||||||||
other receivables, net of allowances of 13,767 and 14,066, respectively | 176,044,000 | |||||||||||||||||||||
inventories, net of allowances of 3,184 and 7,447, respectively | 410,231,000 | |||||||||||||||||||||
other intangible assets, net of accumulated amortization of 115,349 and 117,499 respectively | 55,760,000 | |||||||||||||||||||||
common stock 0.001 par value... | 950,000 | 950,000 | ||||||||||||||||||||
grower advance receivables, net of allowances of 9,764 and 9,606, respectively | 102,709,000 | |||||||||||||||||||||
other receivables, net of allowances of 14,213 and 14,066, respectively | 137,162,000 | |||||||||||||||||||||
inventories, net of allowances of 5,051 and 7,447, respectively | 457,660,000 | |||||||||||||||||||||
other intangible assets, net of accumulated amortization of 119,159 and 117,499 respectively | 59,674,000 | |||||||||||||||||||||
grower advance receivables, net of allowances of 9,606 and 5,598, respectively | 72,350,000 | |||||||||||||||||||||
other receivables, net of allowances of 14,066 and 2,850, respectively | 125,908,000 | |||||||||||||||||||||
inventories, net of allowances of 7,447 and 0, respectively | 410,737,000 | |||||||||||||||||||||
other intangible assets, net of accumulated amortization of 117,499 and 119,576 respectively | 62,046,000 | |||||||||||||||||||||
commitments and contingent liabilities: | ||||||||||||||||||||||
common stock—0.001 par value... | 950,000 | |||||||||||||||||||||
grower advance receivables, net of allowances of 5,813 | 18,731,000 | 18,731,000 | ||||||||||||||||||||
other receivables, net of allowances of 598 | 40,268,000 | 40,268,000 | ||||||||||||||||||||
inventories | 133,356,000 | 133,356,000 | ||||||||||||||||||||
other intangible assets, net of accumulated amortization of 119,606 | 62,527,000 | 62,527,000 | ||||||||||||||||||||
other current liabilities | 39,384,000 | 59,187,000 | 39,384,000 | |||||||||||||||||||
common stock—0.01 par value... | 4,881,000 | 4,881,000 | ||||||||||||||||||||
grower advance receivables, net of allowances of 9,572 and 5,598, respectively | 100,800,000 | |||||||||||||||||||||
other receivables, net of allowances of 13,287 and 2,850, respectively | 115,550,000 | |||||||||||||||||||||
inventories, net of allowances of 4,018 and 0, respectively | 421,762,000 | |||||||||||||||||||||
other intangible assets, net of accumulated amortization of 119,995 and 119,575, respectively | 63,221,000 | |||||||||||||||||||||
common stock— 0.001 par value... | 949,000 | |||||||||||||||||||||
current assets | 1,721,483,000 | |||||||||||||||||||||
current liabilities, less current portion of long-term debt and bank overdrafts | 1,355,929,000 | |||||||||||||||||||||
total debt and bank overdrafts | 1,342,154,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating activities | ||||||||||||||||||
net income | 37,735,000 | 6,002,000 | 13,825,000 | 17,989,000 | 44,159,000 | -31,597,000 | 21,515,000 | 88,065,000 | 65,436,000 | 28,934,000 | 53,985,000 | 52,307,000 | 20,483,000 | 13,305,000 | 46,604,000 | 48,496,000 | 3,285,000 | -24,576,000 |
income from discontinued operations, net of taxes | ||||||||||||||||||
income from continuing operations | 37,735,000 | 6,805,000 | 24,061,000 | 52,939,000 | 44,129,000 | 29,634,000 | 15,131,000 | 56,047,000 | 71,487,000 | 23,136,000 | ||||||||
adjustments to reconcile income from continuing operations to net cash from operating activities - continuing operations: | ||||||||||||||||||
depreciation and amortization | 28,068,000 | 29,016,000 | 28,868,000 | 28,233,000 | 26,544,000 | 26,186,000 | 24,237,000 | 24,274,000 | 24,121,000 | 27,260,000 | 18,901,000 | 25,716,000 | 32,291,000 | 33,170,000 | 33,057,000 | 33,757,000 | 31,013,000 | 30,418,000 |
impairment and asset write-downs of property, plant and equipment and lease assets | 1,112,000 | |||||||||||||||||
net gain on sale of assets | -667,000 | -1,079,000 | -842,000 | -9,323,000 | -3,801,000 | |||||||||||||
net gain on sale of businesses | -1,192,000 | -54,000 | -143,000 | -48,000 | -361,000 | |||||||||||||
net loss on financial instruments | -6,128,000 | -2,057,000 | -3,671,000 | 21,214,000 | 4,822,000 | 506,000 | ||||||||||||
stock-based compensation expense | 1,538,000 | 1,854,000 | 1,815,000 | 1,738,000 | 1,447,000 | 1,861,000 | 1,957,000 | 2,301,000 | 1,832,000 | 1,664,000 | 1,613,000 | 1,438,000 | 1,330,000 | 1,382,000 | 1,137,000 | 1,333,000 | 648,000 | |
equity method earnings | -1,600,000 | -7,362,000 | -6,559,000 | -8,501,000 | -8,292,000 | 403,000 | -2,303,000 | -5,406,000 | -1,002,000 | -3,683,000 | -5,342,000 | -4,688,000 | -1,478,000 | -2,698,000 | ||||
amortization of debt discounts and debt issuance costs | 786,000 | -606,000 | 2,079,000 | 1,364,000 | 1,290,000 | 1,491,000 | 1,475,000 | 3,189,000 | 1,591,000 | 1,602,000 | 1,602,000 | 1,597,000 | 1,589,000 | 1,667,000 | 1,593,000 | 1,487,000 | 1,466,000 | 1,730,000 |
deferred tax benefit | -1,269,000 | 4,906,000 | -2,315,000 | -516,000 | -5,235,000 | |||||||||||||
pension and other postretirement benefit plan cost | 2,142,000 | |||||||||||||||||
dividends received from equity method investments | 2,114,000 | 2,476,000 | 6,071,000 | 197,000 | 801,000 | 1,245,000 | ||||||||||||
gain on insurance proceeds | -5,905,000 | -7,673,000 | -2,462,000 | -1,407,000 | ||||||||||||||
other | 10,000 | 1,700,000 | 228,000 | -200,000 | -1,365,000 | -425,000 | 288,000 | 4,548,000 | -4,658,000 | 10,386,000 | -3,968,000 | 933,000 | -3,083,000 | 423,000 | -178,000 | -205,000 | -234,000 | 1,463,000 |
changes in operating assets and liabilities: | ||||||||||||||||||
receivables, net of allowances | -43,266,000 | 78,617,000 | 8,510,000 | -67,588,000 | -144,356,000 | 68,411,000 | 38,176,000 | -4,028,000 | -123,162,000 | 44,936,000 | 36,686,000 | -20,421,000 | -2,407,000 | 55,604,000 | -44,927,000 | 123,053,000 | -114,022,000 | 99,549,000 |
inventories | 16,539,000 | -62,415,000 | -31,319,000 | 24,316,000 | 1,420,000 | -61,674,000 | -5,364,000 | 39,833,000 | -43,605,000 | -5,954,000 | -29,113,000 | 62,523,000 | -6,768,000 | 22,395,000 | -51,272,000 | 39,387,000 | -48,762,000 | -6,149,000 |
prepaids, other current assets and other assets | -16,664,000 | 2,936,000 | 12,572,000 | -11,071,000 | -1,745,000 | 3,751,000 | 3,250,000 | -5,839,000 | -1,443,000 | |||||||||
accounts payable, accrued liabilities and other liabilities | -41,725,000 | 36,000,000 | 42,018,000 | -19,593,000 | 1,803,000 | 97,334,000 | 15,246,000 | -68,350,000 | 86,359,000 | |||||||||
net cash from operating activities - continuing operations | -22,467,000 | 96,265,000 | 87,387,000 | 18,343,000 | -78,789,000 | 156,475,000 | 100,988,000 | 40,214,000 | -34,956,000 | 141,471,000 | ||||||||
investing activities | ||||||||||||||||||
sales of assets | 1,644,000 | 1,552,000 | 2,017,000 | 5,252,000 | 4,824,000 | 2,186,000 | 927,000 | 875,000 | 1,023,000 | 19,454,000 | 45,541,000 | 12,033,000 | 6,529,000 | 8,912,000 | 1,220,000 | 10,924,000 | 15,620,000 | 12,439,000 |
capital expenditures | -21,114,000 | -19,891,000 | ||||||||||||||||
free cash flows | 37,505,000 | -4,664,000 | ||||||||||||||||
proceeds from sale of businesses, net of transaction costs and cash transferred | 4,968,000 | 106,000 | ||||||||||||||||
insurance proceeds | 56,000 | 579,000 | 3,145,000 | 15,826,000 | 0 | 0 | 0 | 527,000 | -796,000 | 0 | 0 | |||||||
net sales of unconsolidated affiliates | 223,000 | |||||||||||||||||
net cash from investing activities - continuing operations | -10,838,000 | -21,486,000 | 48,714,000 | -14,387,000 | -31,838,000 | -24,915,000 | -18,655,000 | -17,149,000 | 96,499,000 | -9,351,000 | ||||||||
financing activities | ||||||||||||||||||
proceeds from borrowings and overdrafts | 462,060,000 | 304,530,000 | 382,474,000 | 839,031,000 | 312,077,000 | 243,545,000 | 365,527,000 | 417,163,000 | 490,871,000 | 217,374,000 | 320,895,000 | 477,647,000 | 392,054,000 | 284,857,000 | 325,083,000 | 341,545,000 | 341,795,000 | 430,756,000 |
repayments on borrowings and overdrafts | -403,176,000 | -248,815,000 | -270,708,000 | -403,627,000 | -447,801,000 | -573,994,000 | -275,984,000 | -410,490,000 | -542,145,000 | -347,448,000 | -360,539,000 | -296,795,000 | -541,719,000 | -212,414,000 | ||||
dividends paid to shareholders | -8,599,000 | -7,397,000 | -8,237,000 | -8,169,000 | -7,765,000 | -7,652,000 | -7,710,000 | -7,595,000 | -7,594,000 | -7,500,000 | -7,689,000 | -7,592,000 | -7,592,000 | -7,594,000 | -7,590,000 | -7,590,000 | -7,590,000 | 0 |
dividends paid to noncontrolling interests | -2,042,000 | -14,955,000 | -5,770,000 | -2,192,000 | -3,422,000 | -3,712,000 | -12,272,000 | -7,173,000 | -3,698,000 | -8,650,000 | -14,256,000 | -1,918,000 | -651,000 | -6,393,000 | -10,972,000 | -3,616,000 | -1,239,000 | |
repurchases of ordinary shares | -4,644,000 | |||||||||||||||||
tax payments for net settlement of share-based payments | -3,116,000 | |||||||||||||||||
payment of contingent consideration | -96,000 | -881,000 | -38,000 | 0 | -200,000 | -796,000 | 0 | -18,000 | -1,151,000 | -97,000 | -599,000 | -3,688,000 | ||||||
net cash from financing activities - continuing operations | 40,483,000 | -120,531,000 | -154,909,000 | 70,913,000 | 53,267,000 | -39,010,000 | -49,444,000 | -50,705,000 | -98,686,000 | -71,163,000 | ||||||||
effect of foreign exchange rate changes on cash | -1,864,000 | -871,000 | 12,905,000 | 5,954,000 | 9,692,000 | -2,449,000 | -5,630,000 | -4,926,000 | 513,000 | 2,697,000 | ||||||||
net cash from operating activities - discontinued operations | -803,000 | -3,239,000 | -1,816,000 | -22,054,000 | -805,000 | 4,933,000 | 12,711,000 | 5,753,000 | -6,850,000 | |||||||||
net cash from investing activities - discontinued operations | 0 | -1,776,000 | -3,113,000 | -1,737,000 | -7,154,000 | -4,419,000 | -1,338,000 | -382,000 | -1,789,000 | |||||||||
cash from discontinued operations | -803,000 | -5,015,000 | -4,929,000 | -23,791,000 | -7,959,000 | 514,000 | 11,373,000 | 5,371,000 | -8,639,000 | |||||||||
increase in cash and cash equivalents | 5,314,000 | -18,716,000 | -37,402,000 | -35,125,000 | 37,360,000 | 7,364,000 | -34,613,000 | 16,347,000 | ||||||||||
cash and cash equivalents at beginning of period, including discontinued operations | 267,854,000 | 0 | 0 | 0 | 331,719,000 | 0 | 0 | 0 | 277,005,000 | |||||||||
cash and cash equivalents at end of period, including discontinued operations | 273,168,000 | -46,819,000 | -24,694,000 | 82,845,000 | 256,522,000 | 67,737,000 | 43,095,000 | -18,716,000 | 239,603,000 | |||||||||
supplemental cash flow information: | ||||||||||||||||||
income tax payments, net of refunds | -12,935,000 | -17,979,000 | -44,102,000 | -9,465,000 | -15,224,000 | -6,647,000 | -45,598,000 | -10,498,000 | -14,827,000 | -46,482,000 | ||||||||
interest payments on borrowings | -13,736,000 | -15,247,000 | -16,319,000 | -15,462,000 | -16,657,000 | -17,021,000 | -16,544,000 | -16,438,000 | -17,394,000 | -19,596,000 | -51,053,000 | |||||||
loss from discontinued operations, net of income taxes | ||||||||||||||||||
impairment of goodwill | 0 | 0 | 0 | 36,684,000 | ||||||||||||||
deferred tax expense | -1,642,000 | -11,062,000 | 7,370,000 | |||||||||||||||
pension and other postretirement benefit plan expense | 2,950,000 | 1,667,000 | 1,504,000 | 1,364,000 | 3,422,000 | 894,000 | 96,000 | 992,000 | 3,575,000 | 1,069,000 | 1,121,000 | 1,970,000 | 2,681,000 | |||||
dividends received from equity method investees | 2,185,000 | |||||||||||||||||
sales (purchases) of unconsolidated affiliates | 0 | -9,000 | 1,507,000 | |||||||||||||||
acquisitions, net of cash acquired | 241,000 | -607,000 | 4,000 | -1,001,000 | 1,423,000 | -280,000 | -1,405,000 | 0 | 37,000 | -3,524,000 | -1,399,000 | 3,862,000 | ||||||
repayments on borrowings and overdrafts and payment of debt refinancing fees | -410,719,000 | -514,095,000 | ||||||||||||||||
dividends paid to noncontrolling interests and other noncontrolling interest activity | ||||||||||||||||||
payments of contingent consideration | -458,000 | |||||||||||||||||
effect of foreign currency exchange rate changes on cash | -1,660,000 | -3,146,000 | -11,798,000 | -4,108,000 | 3,863,000 | |||||||||||||
income tax payments, including discontinued operations, net of refunds | ||||||||||||||||||
non-cash investing and financing activities: | ||||||||||||||||||
accrued property, plant and equipment | -5,504,000 | |||||||||||||||||
loss from discontinued operations, net of taxes | 10,236,000 | 34,950,000 | -30,000 | -6,384,000 | -32,018,000 | 6,051,000 | ||||||||||||
impairment and asset write-downs of property, plant and equipment | 8,394,000 | 144,000 | 38,000 | 2,154,000 | ||||||||||||||
noncash debt refinancing expenses | 0 | |||||||||||||||||
purchases of investments | -1,000 | 0 | -1,000 | 0 | -2,000 | -73,000 | -187,000 | 0 | -3,000 | -360,000 | -790,000 | -44,000 | 0 | -2,000 | -412,000 | -24,000 | ||
purchases of unconsolidated affiliates | -466,000 | |||||||||||||||||
other noncontrolling interest activity | -202,000 | -818,000 | -2,000 | -4,000 | -476,000 | |||||||||||||
decrease in cash and cash equivalents | -75,197,000 | |||||||||||||||||
proceeds from sale of businesses, net of transaction costs | 48,000 | 361,000 | ||||||||||||||||
incremental charges on purchase accounting valuation of biological assets and inventory | 681,000 | 36,736,000 | ||||||||||||||||
proceeds from sale of business, net of transaction costs | 200,000 | 1,890,000 | 0 | 115,845,000 | ||||||||||||||
(purchases) sales of unconsolidated affiliates | -1,265,000 | -116,000 | -14,000 | -374,000 | ||||||||||||||
payment of debt issuance costs | -39,000 | 5,000 | -1,025,000 | |||||||||||||||
net gain on sale of assets and asset write-offs | -1,573,000 | 89,000 | -417,000 | |||||||||||||||
net gain on sale of business | 0 | -1,995,000 | -73,950,000 | |||||||||||||||
net gain on financial instruments | 3,155,000 | |||||||||||||||||
impairment of fixed assets | 0 | 1,277,000 | ||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||
net sales (purchases) of investments in unconsolidated affiliates | ||||||||||||||||||
proceeds from exercise of stock options | ||||||||||||||||||
proceeds received from issuance of common stock in initial public offering, net of issuance costs | 0 | |||||||||||||||||
incremental charges on biological assets related to the acquisition of legacy dole | ||||||||||||||||||
net (gain) on sale of assets and asset write-offs | -28,810,000 | -10,723,000 | -3,973,000 | |||||||||||||||
deferred tax | -10,690,000 | |||||||||||||||||
prepaids, accrued and other current and long-term assets and liabilities | ||||||||||||||||||
(decrease) in cash and cash equivalents | ||||||||||||||||||
cash and cash equivalents at beginning of period | 0 | 0 | 228,840,000 | 0 | 0 | 0 | 250,561,000 | 0 | ||||||||||
cash and cash equivalents at end of period | -13,552,000 | -35,125,000 | 266,200,000 | 7,364,000 | -17,314,000 | 22,842,000 | 215,948,000 | 16,347,000 | ||||||||||
accrued and other current and long-term liabilities | -47,862,000 | -32,097,000 | -30,981,000 | 34,829,000 | 24,476,000 | -32,161,000 | -92,844,000 | |||||||||||
net cash from operating activities | 58,619,000 | 15,227,000 | ||||||||||||||||
net cash from investing activities | -7,889,000 | -14,033,000 | ||||||||||||||||
net cash from financing activities | -86,368,000 | 33,469,000 | ||||||||||||||||
incremental charges on purchase accounting valuation of biological assets and inventory related to the acquisition of legacy dole | ||||||||||||||||||
impairment of property, plant and equipment | ||||||||||||||||||
net (gain) on disposal of businesses | ||||||||||||||||||
fair value movement on contingent consideration | -78,000 | 23,000 | 16,000 | 25,000 | -94,000 | |||||||||||||
cash flow from operating activities | 117,337,000 | -384,000 | 35,639,000 | |||||||||||||||
proceeds from sales of investment in unconsolidated affiliates | ||||||||||||||||||
investments in unconsolidated affiliates | -2,649,000 | -453,000 | -300,000 | -48,000 | ||||||||||||||
cash flow from investing activities | -23,889,000 | -15,382,000 | ||||||||||||||||
acquisition of redeemable noncontrolling interest | ||||||||||||||||||
cash flow (used in) financing activities | ||||||||||||||||||
asset write-offs and net gain on sale of assets | -654,000 | -7,926,000 | -495,000 | |||||||||||||||
net loss on disposal of businesses | -606,000 | |||||||||||||||||
provision for deferred income taxes and other tax-related liabilities | ||||||||||||||||||
pension and other postretirement benefit plan benefit cost | ||||||||||||||||||
net gain on acquisitions and disposals of equity method investments | ||||||||||||||||||
operating lease liabilities | 7,921,000 | -5,255,000 | 1,037,000 | |||||||||||||||
proceeds from sale of investments in unconsolidated affiliates | ||||||||||||||||||
proceeds from exercise of share options | ||||||||||||||||||
cash flow from financing activities | 12,555,000 | -219,103,000 | 117,576,000 | -7,773,000 | ||||||||||||||
incremental charges on purchase accounting valuation of biological assets | 17,431,000 | 17,513,000 | ||||||||||||||||
equity in net earnings of investments accounted for under the equity method | ||||||||||||||||||
net gain on disposal of businesses | 0 | -242,000 | ||||||||||||||||
gain on disposal of investments in unconsolidated affiliates | ||||||||||||||||||
fair value gain on remeasurement of investments in unconsolidated affiliates | ||||||||||||||||||
benefit for deferred income taxes | -5,134,000 | -4,078,000 | ||||||||||||||||
pension and other postretirement benefit plan benefit | 934,000 | -1,023,000 | ||||||||||||||||
dividends received | 3,674,000 | 810,000 | 1,422,000 | |||||||||||||||
dole transaction costs | ||||||||||||||||||
insurance proceeds received for damage to property | 1,502,000 | 776,000 | 238,000 | |||||||||||||||
cash flow (used in) investing activities | ||||||||||||||||||
proceeds from issuance of shares | ||||||||||||||||||
earnings from equity method investments | -577,000 | |||||||||||||||||
cash flow used in operating activities | -145,291,000 | |||||||||||||||||
cash flow used in investing activities | -2,790,000 | |||||||||||||||||
non-cash lease expense | 14,188,000 | |||||||||||||||||
asset write-offs and net (gain) on sale of assets | ||||||||||||||||||
net unrealized (gain) on financial instruments | -1,115,000 | |||||||||||||||||
share-based payment expense | ||||||||||||||||||
(earnings) from equity method investments | -11,029,000 | |||||||||||||||||
(benefit) for deferred income taxes | ||||||||||||||||||
proceeds from sales of equity method investments | 0 | |||||||||||||||||
repayments on short-term borrowings and overdrafts | -430,645,000 | |||||||||||||||||
acquisition of noncontrolling interest subject to put options | ||||||||||||||||||
net (gain) on acquisitions and disposals of equity method investments | ||||||||||||||||||
provision for deferred income taxes | ||||||||||||||||||
investments in non-consolidated affiliates | ||||||||||||||||||
interest expense from continuing operations | ||||||||||||||||||
income tax (benefit) expense from continuing operations | ||||||||||||||||||
ebit | ||||||||||||||||||
merger, transaction and other related costs | ||||||||||||||||||
net unrealized gain on derivative instruments | ||||||||||||||||||
net unrealized (gain) on foreign denominated intercompany borrowings | ||||||||||||||||||
fair value movements on contingent consideration | ||||||||||||||||||
asset write-downs, net of insurance proceeds | ||||||||||||||||||
fair value loss on acquisition of legacy dole | ||||||||||||||||||
fair value gain on other acquisitions | ||||||||||||||||||
gain on disposal of equity method investments | ||||||||||||||||||
loss on disposal of businesses | ||||||||||||||||||
incremental charges on biological assets and inventory related to acquisition of legacy dole | ||||||||||||||||||
items in earnings for equity method investments: | ||||||||||||||||||
dole’s share of depreciation and amortization | ||||||||||||||||||
dole’s share of income tax (benefit) expense | ||||||||||||||||||
dole’s share of interest expense | ||||||||||||||||||
dole’s share of other items | ||||||||||||||||||
adjusted ebitda | ||||||||||||||||||
adjusted ebitda per share – basic | ||||||||||||||||||
adjusted ebitda per share – diluted | ||||||||||||||||||
weighted-average shares outstanding – basic | ||||||||||||||||||
weighted-average shares outstanding – diluted | ||||||||||||||||||
fresh fruit | ||||||||||||||||||
fresh vegetables | ||||||||||||||||||
diversified produce – emea | ||||||||||||||||||
diversified produce – americas & row | ||||||||||||||||||
intersegment sales | ||||||||||||||||||
adjusted ebitda: | ||||||||||||||||||
legacy dole |